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Background: Self assessment of arthritis is important for recognition of disease activity and early initiation of
therapy. Proper interpretation of physical symptoms is necessary for this. The purpose was to investigate the
assessment by patients and parents of disease activity in juvenile idiopathic arthritis (JIA) and to compare their
assessments to rheumatologists’ assessments.
Methods: Patients and parents assessed 69 joints on a paper homunculus and marked each joint with a different
color according to presumed presence of disease: active disease (AD), doubt, and non-active disease (NAD). Their
assessments were compared to the rheumatologists’ assessments. If patients and/or parents marked an inflamed
joint, it counted as AD. Pain, functional impairment, and disease duration were analyzed to differentiate more
precise between true and false positive and true and false negative assessments.
Results: We collected assessments of 113 patients and/or parents. AD was assessed 54 times, 33 of which were
true positives. NAD was assessed 23 times, 22 of which were true negatives. Doubt was expressed 36 times, 9 of
which were assessed by the rheumatologist as AD. Sensitivity and specificity of AD was 0.77 and 0.31. Pain and
functional impairment scored highest in AD, intermediate in doubt, and lowest in NAD.
Conclusion: Patients and/or parents seldom missed arthritis but frequently overestimated disease activity. Pain,
functional impairment, disease duration, gender, and age did not differentiate between true and false positives for.
Patients perceived JIA as active if they experienced pain and functional impairment. To reduce overestimation of
the presence of AD we need to improve their understanding of disease activity by teaching them to distinguish
between primary symptoms of JIA and symptoms like pain and functional impairment.
Keywords: Juvenile idiopathic arthritis, Pain, Self care, Self reportBackground
Juvenile idiopathic arthritis (JIA) is a chronic autoimmune
disease characterized by periods of active disease alter-
nated by periods of remission. Forty to sixty percent of
patients achieve remission and stay in remission with-
out medication for varying lengths of time [1,2]. Disease* Correspondence: w.armbrust@umcg.nl
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reproduction in any medium, provided the oractivity in JIA can be determined by core set criteria [3,4]
and the juvenile arthritis disease activity score [5,6]. These
methods include parent and patient assessments on global
disease activity, the erythrocyte sedimentation rate, assess-
ments by pediatric rheumatologist of pain, limitation, and
inflammation of all joints, and rating global disease activ-
ity [3-7]. Whether arthritis is actually present is a key issue
in determining disease activity and initiating treatment.
Although disease activity is assessed regularly by a
rheumatologist, early detection of disease activity at home,
between scheduled consultations, is a major concern.al Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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should be treated as soon as symptoms appear. Treatment
must be aimed at early remission so as to prevent long-
term complications as joint damage and to improve prog-
nosis [8-10]. Underestimating disease activity by patients
and their parents invariably leads to delayed treatment
with joint damage as a consequence. It is equally import-
ant not to overestimate disease activity. Overestimation
may lead to the patient taking less part in sport and leisure
activities, missing school, and excessive medication. The
reduced levels of activity that result in the deterioration of
physical fitness are a major concern in JIA patients. A
previous study reported decreased physical fitness in JIA
patients even during periods of remission [11,12]. It is ne-
cessary to stimulate active participation in sport and other
activities, while at the same time fine-tuning these activ-
ities to disease activity. Early control of disease activity can
lead to rapid remission and timely return to daily activities
[11-14]. For these reasons it is important that we educate
patients and parents to assess disease activity accurately.
The reliability of self-reported counts of swollen joint
by adults with rheumatoid arthritis compared to the as-
sessments by rheumatologists and/or ultrasonography is
poor [15-18]. In children with JIA self-assessment of dis-
ease activity by the patients and/or their parents by indi-
cating inflamed joints has not been investigated. A study
on rating global disease activity using Visual Analogue
Scales (VAS) showed discordance between parents’ and
rheumatologists’ assessments. This was evident espe-
cially in cases where the patient had awarded high scores
for pain and had indicated significant functional impair-
ments or in cases where the rheumatologist had indi-
cated disease activity in a large number of joints [19,20].
Correct assessment at home is important in order to re-
port disease activity to the rheumatologist without delay
and so preventing the patient from feeling more limited
than necessary. Pinpointing arthritis to one particular joint
may be difficult for patients and/or parents while, in fact,
the important issue is to determine the presence of disease
activity. Indicating disease activity in another joint than
the one identified by the rheumatologist is not necessarily
a wrong assessment, since it may still lead to early detec-
tion of disease activity. Correct assessment of disease ac-
tivity in a particular joint is, therefore, less important than
correct assessment of disease activity per se.
The aim of our study was to evaluate the assessment
of disease activity in children with JIA by patients and/




All patients aged 4 to18 years and their parents attending
the outpatient clinics of the Beatrix Children’s Hospital,University Medical Center Groningen and the Wilhelmina
Children’s Hospital, University Medical Center Utrecht
between March and June 2010, and who were diag-
nosed with JIA according to the revised criteria of the
International League of Associations for Rheumatology
(ILAR) [21], were eligible subjects. Any patient not living
with the parent that accompanied him or her on a daily
basis was excluded, as were patients and/or parents
not in command of Dutch or English. According to the
Institutional Review Board of both hospitals was this study
exempt from approval. Therefore no written informed
consents were obtained from parents and/or children.
We collected information on patient characteristics such
as age, gender, and disease duration. Patients were catego-
rized according to the ILAR criteria [21]. Extended oligoar-
ticular JIA, rheumatoid factor positive and rheumatoid
factor negative, and polyarticular JIA were considered as
one group.
Fifteen to thirty minutes prior to the visit to the
pediatric rheumatologist (hereafter referred to as the
rheumatologist), the patient and one or both parents
were asked to independently assess 69 joints on a paper
homunculus. Patients younger than nine years were
assisted by an independent student, after this age both
patient and parent each filled out an assessment form
separately. The homunculus (Figure 1) displayed all joints,
except those judged as too difficult to assess, i.e. the acro-
mioclavicular joint, and the thoracic and lumbar joints of
the spine. The ankle and wrist were scored as a collective
joint. Patients were instructed to mark the joints with
three different colors: in case arthritis was presumed ac-
tive in a joint it was marked red, in case of doubt it was
marked yellow, and in case no disease activity was per-
ceived it was marked green. At the time JIA had been di-
agnosed, the symptoms of arthritis had been explained to
the patient and their parents by their own rheumatologist
as part of routine practice. Thus, when the homunculus
was handed out no further instruction on how to identify
arthritis was given.
After the rheumatologist had seen the patient he or
she also marked the joints on the homunculus according
to the same instruction when to use red, yellow, or
green. The rheumatologist was blinded for the results of
the patients and parents.
Prior to their visit to the rheumatologist patients were
asked to complete the Dutch version of the Childhood
Health Assessment Questionnaire (CHAQ) for the last
seven days before the visit. It measures functional im-
pairment in eight domains, i.e. getting up, dressing and
grooming, eating, walking, hygiene, reaching, gripping,
and activities [22]. Scores range from 0 to 3, where 0
stands for no impairment and 3 for maximum impair-
ment. The patient and/or the parents also filled out the
Visual Analogue Scale (VAS) to measure pain. It ranges
Figure 1 Homunculus.
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for no pain and 100 for maximum pain. If the patients
were younger than nine years the parents completed the
CHAQ and the VAS with consulting the patients.
Analysis
Disease activity
Disease activity was based on the overall joint assess-
ments made by the patient, the parent, and the rheuma-
tologist. The patients’, parents’, and rheumatologists’
assessments were divided into three categories: active
disease (AD) if at least one joint was colored red, non-
active disease (NAD) if all the joints were colored green,
and doubt if at least one joint was colored yellow in the
absence of any red joints.
Patients’ and/or parents’ assessments compared to the
rheumatologists’ assessments
The assessments by the patients and/or parents were
compared to the assessments by the rheumatologists.
The latter assessments were regarded as the criterion
standard, since this is standard procedure when ultra-
sound examinations are not routinely performed [23,24].
The assessments were divided into six categories: true
positive, false positive, true negative, false negative,
doubt expressed by either patient or parent while therheumatologist indicated AD, and doubt expressed by
either patient or parent while the rheumatologist indi-
cated NAD. In order to examine whether patients and
parents together were better able to assess AD, their as-
sessments were combined whereby a positive score
awarded by either the parent or the child was considered
as positive. The choice to analyze the combined assess-
ments stemmed from our opinion, that the consequences
of missing AD are more harmful than if it were overesti-
mated. We examined the combined assessments in the
same way as the separate ones. At home, in case of pre-
sumed disease activity, the decision of the patients or their
parents, to either contact a rheumatologist or not, will
generally be a joint conclusion arrived at by both the pa-
tients and their parents. Subsequent analyses were, there-
fore, performed with the combined assessments.
Sensitivity and specificity
We calculated the sensitivity and specificity of the pa-
tients’ and parents’ assessments separately and of the
combined assessments.
Analysis of the variables that influenced parents’ and/or
patients’ assessments
We analyzed whether the variables of functional ability
(based on CHAQ), pain (based on VAS), gender, age,
and disease duration influenced patients’ and/or parents’
opinion about the presence or absence of JIA, and
whether these variables discriminated between AD and
NAD as assessed by the rheumatologist.
Results
One hundred and thirteen patients, whose main charac-
teristics are presented in Table 1, were included together
with at least one parent. None of the patients refused to
participate. None of the patients had extra articular
manifestations as fever rash or enthesitis.
Disease activity
In Table 2 we show the results of the assessments by the
patients, the parents, and the combination of patients
and parents, compared to the assessments of the rheu-
matologists. Patients indicated AD in 50 cases, doubt in
34 cases, and NAD in 29 cases. Parents indicated AD in
41 cases, doubt in 43 cases, and NAD in 29 cases. The
combination of patients’ and parents’ assessments shows
AD in 54 cases, doubt in 36 cases, and NAD in 23 cases.
Rheumatologists assessed AD in 43 patients and NAD in
70 patients and doubt was expressed three times. In all
these last cases this resulted in adjusting treatment by,
for example, advancing regular consultations or more
detailed tests. Therefore, in those situations where the
rheumatologists had expressed doubt, we considered it a
case of AD.
Table 1 Patient characteristics
Characteristic Sample (%) Median (range) Mean (SD)
n = 113
Gender
− Male 37 (32.7)
− Female 76 (67.3)
Age (years) 11.4 (3.8) 12 (3-18)
− <9 27 (23.9)
− 9-12 35 (31.0)
− >12 51 (45.1)
Condition
− Oligoarthritis 43 (38.1)
− Polyarthritis* 55 (48.7)
− ERA† 4 (3.5)
− Systemic JIA# 9 (8.0)
− Other arthritis 2 (1.8)
Disease duration (months) 59.1 (49.5) 48 (0-192)
− = < 12 22 (19.5)
− = > 13 91 (80.5)
CHAQ score .41 (.52) .13 (0-2.38)
− 0 45 (39.8)
− = < 1 45 (39.8)
− >1 19 (16.8)
− Missing 4 (3.5)
*Including extended oligo arthritis, †Enthesitis related JIA, #No extra-articular
manifestations were present at time of the study.
Table 2 Patients’ and/or parents’ assessments compared




Patient 31 (.72)* 19 (.27) 50 (.44)
Parent 30 (.70)* 11 (.16) 41 (.36)
Combination 33 (.77)* 21 (.30) 54 (.48)
Doubt C D
Patient 10 (.23) 24 (.34) 34 (.30)
Parent 12 (.28) 31 (.44) 43 (.38)
Combination 9 (.21) 27 (.39) 36 (.32)
NAD E F
2 (.05) 27 (.39)† 29 (.26)
1 (.02) 28 (.40)† 29 (.26)
1 (.02) 22 (.31)† 23 (.20)
Total
Patient 43 [1] 70 [1] 113 [1]
Parent 43 [1] 70 [1] 113 [1]
Combination 43 [1] 70 [1] 113 [1]
NAD = Non-active disease, AD = Active disease, A = True positive, B = False
positive, C = Doubt in NAD, D = Doubt in AD, E = False negative, F = True
negative, n(percentage).
*n (sensitivity), †n (specificity).
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patient/parent assessments were 0.77 (cell A, true posi-
tives) and 0.31 (cell F true negatives), respectively. If
doubt was interpreted as AD, sensitivity increased to
0.98 (cells A + C). But the specificity remained low at
about 0.31 (cell F). These results indicate that AD was
rarely missed, while it is overrated considerably.
Positive agreement, i.e. the agreement between pa-
tients and parents on the presumed presence of JIA, was
87%. These results confirmed our choice to perform fur-
ther analyses with the combined assessments of parents
and patients because we assumed that the decision taken
at home to either contact the rheumatologist or not, will
be arrived at by patient and parent together.
Our analysis of the factors that influenced the parents’
and patients’ assessment revealed interesting facts. In
Table 3 we present the results of the patient characteris-
tics, the pain scores, and functional abilities in relation
to the presence or absence of disease activity. Age of the
patients, gender, and duration of disease did not differ
between cases with and without AD. The pain scores, as
indicated by patients and/or parents as well as scores of
functional impairment, were highest in the category inwhich patients and/or parents scored AD (cells A + B).
Within this category pain scores and functional impair-
ment were not different between the true positive and
false positive assessments. Pain scores and functional im-
pairment were intermediate in the category where patients
and/or parents expressed doubt (cells C + D). There were
no differences in this group between AD or NAD as
assessed by the rheumatologists. Functional impairment
scores approaching zero were seen in assessments in
which NAD was rated by the patients and/or parents irre-
spective of whether this assessment was a true negative or
a false negative (cells E + F).
Discussion
This is the first study in children with JIA that compared
the assessment of disease activity by color-coding the
joints displayed on a homunculus by patients and/or par-
ents to the assessments of rheumatologists. We found that
patients and/or parents more frequently presumed disease
activity to be present. In only one case had the rheuma-
tologist indicated disease activity that had not been indi-
cated by the patients and/or parents. Parents and patients
agreed strongly on the presence or absence of disease
activity. For patients pain and functional impairment were
important determinants in the assessment of active dis-
ease, but these variables did not discriminate between cor-
rect and false assessments.




N =33 N =21
Age 11.2 (4.2) 11.2 (3.7)
Gender (M:F) 12:21 4:17
VAS patient 33.5 (28.0) 27.9 (30.1)
VAS parent 31.6 (25.5) 38.5 (30.9)
CHAQ 0.7 (0.6) 0.6 (0.4)
Dis.duration 53.1 (52.9) 60.1 (49.5)
Doubt C D
N =9 N =27
Age 11.8 (3.2) 12.2 (3.6)
Gender (M:F) 2:7 9:18
VAS patient 19.0 (27.0) 17.0 (19.9)
VAS parent 20.4 (25.1) 18,2 (23.8)
CHAQ 0.3 (0.5) 0.3 (0.4)
Dis. duration 54.2 (39.3) 77.3 (51.9)
NAD E F
N =1 N =22
Age 6.0 11.1(3.8)
Gender (M:F) M = 1 9:13
VAS patient 20 (0) 0,9 (1.6)
VAS parent 0.0 (0) 0.9 (2.0)
CHAQ 0 (0) 0.04 (0.1)
Dis.duration 44 47.4 (43.8)
NAD = Non-active disease, AD = Active disease, A = True positive, B = False
positive, C = Doubt in NAD, D = Doubt in AD, E = False negative,
F = True negative.
Age in years, M =male, F = female, VAS pain patient and parent 0-100 mm,
Dis duration = disease duration in months.
Mean (SD).
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patients and parents are able to accurately assess the
current state of JIA. If they are able to detect disease
activity correctly, it will be treated as soon as it is recog-
nized so as to achieve early remission and to prevent
long-term damage [8]. If parents and patients are able to
assess disease activity adequately, regular consultations
can be adjusted accordingly. If patients underestimate
disease activity adequate medical treatment may be de-
layed and they may exceed their physical limits, the
consequences of which are unknown. Finally, if pa-
tients are to overestimate disease activity this may lead
to their taking part less in sport and leisure activities.
This is an undesirable state of affairs because the
already existing reduced level of physical fitness and
exercise capacity of patients with JIA may be reduced
even further [11-13].We found that patients and/or parents overestimated
disease activity more frequent than that they missed dis-
ease activity. A considerable number of patients and/or
parents expressed doubt about disease activity. Taking
into consideration the fact that the consequences of
missing active disease are more harmful than overesti-
mating disease activity, patients and parents who express
doubt should be advised to consult their rheumatologist.
Our results show that if consultations are to be regu-
lated on the basis of patients’ and/or parents’ assess-
ments, barely any case of active disease will be missed,
but it will lead to many unnecessary visits. During such
visits, however, patients can be reassured that the disease
is currently not active and the patients could be stimu-
lated to continue or increase their normal daily activities
and sport.
Why parents and patients overestimated disease activ-
ity is an interesting question. One explanation could be
that parents and patients are more afraid of missing dis-
ease activity than of overestimating it. Most patients had
a long history before JIA was diagnosed during which
symptoms were underestimated or misinterpreted, and
this has a marked psychological impact [25,26]. Secondly,
parents and patients are aware that delaying treatment
when the disease is active could be harmful, thus rather
overestimate disease activity just to be at the safe side.
In this study we took the rheumatologist’s assessment
as the criterion standard, which is common practice.
Current disease activity scores are based on clinical and
laboratory parameters combined with rheumatologists’
assessments [3-6]. Laboratory parameters were not in-
cluded in this study while pure clinical parameters were
compared. One could, however, question the reliability
of a rheumatologist’s joint assessments. Good interob-
server reliability between rheumatologists of articular as-
sessment in children with JIA was reported [27]. More
recent publications, however, showed that the presence
and absence of arthritis as assessed by the rheumatolo-
gist or the patient is not always confirmed by ultrasound
[17,28-31]. That rheumatologists sometimes miss disease
activity could possibly be an explanation for the overesti-
mation of disease activity by patients and/or parents as
we found in our study. The value of ultrasound and MRI
to monitor disease activity in patients with JIA seems
promising but has yet to be investigated in more detail
[31-34]. We found that patients who indicated active
disease and those who expressed doubt both had high
pain scores and experienced functional impairment in
executing their daily activities. Analysis of functional im-
pairment, pain, and disease duration in the patients did
not differentiate between those with AD as assessed by
the rheumatologist and those without AD. Functional im-
pairment, pain, and disease duration also did not differen-
tiate between true positive and false positive assessments
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ents’ and/or patients’ perception of disease activity was
based on pain and impairment.
This finding confirmed the work by Consolaro et al.,
who studied agreement on disease activity ratings be-
tween parents and rheumatologists as measured by glo-
bal assessment scores [19]. They also found that parents
tended to award higher disease activity scores compared to
the rheumatologist if their child felt pain or was impaired.
It makes no difference whether patients and parents were
asked to fill out a global assessment or whether they had
to make a more precise joint count on a homunculus as
we required in our study. A recent study on adult patients
with rheumatoid arthritis showed that the most significant
determinants for discrepancies between the patients’ and
the rheumatologists’ assessments of global disease activity
scores are pain and joint swelling [35]. Adult patients’
assessments of disease activity by means of a joint count
on a homunculus compared to those of rheumatologists’
appears to be unreliable [16].
Pain is a major problem in children with JIA and it is
not always related to disease activity or damage. It can
be caused by pathophysiological and psycho-emotional
factors [36-42]. Pain is related to well-being and should
be a major concern in the treatment of children with JIA
[43]. In our opinion, monitoring pain and well-being are
important in the management of JIA and it needs the
attention of the clinicians, but we question whether these
subjective patient-related factors should be included in the
assessment of disease activity.
We need to teach patients and their parents to recognize
the symptoms of JIA and how to recognize current disease
activity. This is necessary so medical treatment can be ini-
tiated promptly in case of AD and normal activities can be
continued or resumed in case JIA is not active. If the pa-
tient perceives the disease as being active while this is not
confirmed by the rheumatologist, the reasons on which
the patient bases his or her assessment should be dis-
cussed. If pain and functional impairment are the patient’s
main reasons for presuming the presence of JIA, while it is
not confirmed by the rheumatologist, more detailed tests
are needed to exclude whether local deconditioning, dam-
age, or emotional factors are involved.
True AD requires adjustment of medication, while other
factors leading to AD being perceived requires education
and proper counseling. Efficient self-management is im-
portant if patients are to cope with a chronic disease
[44-46]. It is important, therefore, that children with JIA
learn to recognize the symptoms and that they are treated
correctly.
We identify some limitations of this study. We did not
take into account whether a joint that had been affected in
the past was more frequently marked as being inflamed
again. As a consequence, we were unable to determinewhether arthritis in the past had influenced current as-
sessment. Another limitation was that we did not ask on
what grounds a patient and/or a parent considered the
disease to be active in a joint. Thirdly, we did not identify
morning stiffness what was added in the latest criteria of
remission [47]. Morning stiffness could be a factor that el-
evates the positive predictive value of the assessments of
the patients and parents. Finally we did not use ultrasound
to verify the rheumatologists’ assessments.
Conclusion
In this study we found that patients and parents barely
missed arthritis while overestimation occurred frequently.
The perceived presence of arthritis was related to the
presence of pain and functional impairment. In order to
reduce the frequency of over-reporting active disease, we
need to educate both patients and their parents to distin-
guish between pain, impairment and disease activity, and
to recognize the presence of active disease unerringly.
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